Potent Immune Response with Vernal’s LNP-mRNAs
By Julia Sakamoto, Marketing Specialist The development of mRNA vaccines has been ongoing since the late 80s, but it wasn’t until the COVID-19 pandemic that this technology became widely recognized. Instead of using an antigen to trigger the body’s immune system to create a new antibody, mRNA can give direct instructions on how to fight…
Vernal’s First Newsletter!
Download our newsletter and sign up for the next one below: Download the Newsletter and Sign Up – Complete the Form Below
Vernal’s mRNA Health Conference Poster
Didn’t have a chance to attend the 2022 mRNA Health Conference? Download a copy of our poster regarding the “Design, formulation, and manufacturing of LNP-mRNA for clinically relevant applications” authored by our very own LNP SMEs, Elias Henderson, Noah T. Prugar, Lynda M. Menard, and Joseph J. Bivona III. Download the Poster – Complete the…
Connect With Vernal’s Experts at the 10th International mRNA Health Conference!
Vernal is proud to be the Silver Sponsor for this exciting event! Connect with one of Vernal’s experts on November 8-10, 2022 in Boston and meet them at our booth for discussions about your mRNA and LNP projects. Schedule a Meeting with us!
Construction begins on Vernal’s new mRNA manufacturing facility in Vermont!
Vernal Biosciences is excited to announce the start of construction on its new, 23,000 square foot mRNA manufacturing facility in Essex Junction, Vt. The new facility will include state-of-the-art equipment and clean rooms to support clinical mRNA and LNP mRNA manufacturing. The upgraded space will allow Vernal to better provide customers with scalable product and…
Vernal welcomes Scott Vanson and JJ Bivona to the team
We are excited to announce the addition of two new members to the Vernal team: Scott Vanson, Ph.D. and JJ Bivona, Ph.D.